Malignant Abdominal Neoplasm — Trials

Malignant Abdominal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

64 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Varian, a Siemens Healthineers Company
Termination share: 16.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06915727	An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors	recruiting	Phase 3	20	Mayo ClinicOTHER	1	Apr 1, 2026	clinicaltrials
NCT05533424	Ultrasound Guided Quadratus Lumborum Block Versus Transversus Abdominis Plane Block as Postoperative Analgesia in Patients Undergoing Abdominal Cancer Surgery.	unknown	Phase 3	98	Mansoura UniversityOTHER	1	Sep 9, 2022	clinicaltrials